Alwin Huitema
Full Professor
Recent publications
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa
Luka Verrest, Séverine Monnerat, Ahmed M. Musa, Jane Mbui, Eltahir A.G. Khalil, Joseph Olobo, Monique Wasunna, Wan Yu Chu, Alwin D.R. Huitema, Henk D.F.H. Schallig, Fabiana Alves, Thomas P.C. Dorlo
PLoS neglected tropical diseases, 2024, vol. 18
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia
Leiah J. Brigitha, Veerle Mondelaers, Yiwei Liu, Birgitte K. Albertsen, Beata Zalewska-Szewczyk, Carmelo Rizzari, Rishi S. Kotecha, Rob Pieters, Alwin D.R. Huitema, Inge M. van der Sluis
Pharmaceutical Research, 2024, vol. 41, p.711-720
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
Semra Palić, Wan Yu Chu, Shyam Sundar, Dinesh Mondal, Pradeep Das, Krishna Pandey, Sheeraz Raja, Suman Rijal, Ignace C. Roseboom, Abdullah Hamadeh, Paul R.V. Malik, Jos H. Beijnen, Alwin D.R. Huitema, Erik Sjögren, Fabiana Alves, Thomas P.C. Dorlo
Journal of Antimicrobial Chemotherapy, 2024, vol. 79, p.1547-1554
A multiplex UPLC-MS/MS method for the quantification of three PD-L1 checkpoint inhibitors, atezolizumab, avelumab, and durvalumab, in human serum
Pauline L.M. Buitelaar, Karen A.M. de Jong, Leon Aardenburg, Michiel S. van der Heijden, Alwin D.R. Huitema, Jos H. Beijnen, Hilde Rosing
Journal of Pharmaceutical and Biomedical Analysis, 2024, vol. 243
